沙棘在西伯利亚面临的问题与解决办法

针对西伯利亚沙棘繁育发展中的问题，尤其是20世纪30年代从郭尔诺－阿尔泰地区引入的沙棘客体连续出现的品种变化，混杂和应淘汰等问题，指出：这里的沙棘，不但从野生发育形态方面出现诱变，而且目前在西伯利亚仅有20个左右繁育着的品种，在展示着原品种较为完备的特性；能按时结果；树冠低矮；有刺；浆果稳定。总的看，几乎在整个俄罗斯20个区域内传播着，占俄罗斯栽植品种的1／3。当然，每个品种都有有一个生物经济的所有制和栽植前的宣传发布与公认问题，解决这些问题，就能在各种不同地区加强推广和普及。但到目前为止，西伯利亚栽植繁育着的沙棘，还只是不多的原有一些品种，使用的还是过去认为效率高的多样化方法。     

辣椒黄绿苗突变体生物学特性及生长动态研究

对96－140牛角辣椒及96－140辣椒黄绿苗突变体（96－140YBM）生物学特性、生长动态、抗病性等方面进行了测定，试验收结果表明96－140辣椒黄绿苗突变体不仅在生长势，叶片、株重、单果重等方面强于96－140，而且在抗疫病方面明显强于96－140牛角辣椒。96－140YBM性状遗传稳定，苗期遗传标记性状明显，在杂交育种及纯度鉴定上有较大的利用价值。     

O,O-二烷基-N-莰-2-基(硫)磷酰胺酯的合成

合成了14个含有 N-莰-2-基的磷酰胺和硫代磷酰胺类化合物,用红外、核磁及元素分析确定其结构,并探讨了~(31)Pδ值的规律性变化。初步生物试验表明,磷酰胺类化合物对水稻发芽具有明显的抑制作用,其中化合物Ⅱ1的活性大于对照药剂抗倒胺但低于多效唑。     

苹果试管苗不定根起源及其发育状况的研究

利用光学和扫描电子显微镜观察结果表明,经琼脂生根培养基诱导产生的长富—2苹果 (Malus pumila Mill.) 试管苗的不定根起源于维管形成层。这种不定根发育不良,根表面缺乏根毛,内部解剖构造为典型的初生结构。为避免因不定根吸收、运输能力差而影响试管苗移栽成活,宜采用通透性良好的基质进行瓶内或瓶外生根,可诱导出优质不定根。     

Heterosis and recombination effects in Hampshire and Landrace swine: II. Performance and carcass traits.

Twelve different mating types among the Hampshire and Landrace breeds were used to determine direct, maternal, heterosis, and recombination effects for performance and carcass traits. Mating types used were two purebred, two F1, two F2, two F3, and four backcross. Carcass data were collected on 238 barrows and 262 gilts over four replications. Traits measured were length (LENG), 10th rib off midline backfat (BF10), longissimus muscle area (LMA), and dressing percentage (DRS%). Average backfat (AVBF) was calculated as the mean of three midline fat depths measured opposite the first rib, last rib, and last lumbar vertebra. The model used to evaluate the carcass traits included main effects of mating type, farrowing season, and sex and included slaughter weight as a covariate. The performance traits of ADG, feed efficiency (FE), daily feed consumption (DFC), lean gain per day (LNGN), and lean efficiency (LNEF) were measured on a pen basis. Comparisons of reciprocal F1 crosses showed that carcasses from pigs sired by Hampshire boars were leaner and had more LMA than those sired by Landrace boars. Heterosis percentages were significant for AVBF (7.2%; P less than .01), BF10 (8.8%; P less than .01), DRS% (1.5%; P less than .01), ADG (11.5%; P less than .01), DFC (10.2%; P less than .01), LNGN (10.6%; P less than .01), and LNEF (6.0%; P less than .05). Epistatic recombination losses in the offspring were significant for LENG (3.6 cm; P less than .05) and approached significance for BF10 (6.1 mm; P less than .10).     

Pharmacokinetic evaluation of ceftiofur in serum, tissue chamber fluid and bronchial secretions from healthy beef-bred calves.

Ceftiofur is a new broad spectrum cephalosporin marketed for the treatment of acute bovine respiratory disease. In this investigation ceftiofur was administered by intramuscular injection, at 24 h intervals, to healthy beef-bred calves for four days at dosages of 2.2 and 4.4 mg/kg of body weight, with 4 wk intervals between dosing regimens. Serum, tissue chamber fluid (TCF), and bronchial secretion (BS) concentrations of ceftiofur were measured by microbiological assay after the first and fourth dose of each dosing regimen. Peak serum concentrations (Cmax) of 8.8 micrograms/mL and 17.3 micrograms/mL were obtained approximately 2 h (Tmax), the time of mean peak concentration) after single injections of 2.2 mg/kg and 4.4 mg/kg, respectively. The Cmax was increased approximately twofold following multiple doses of 2.2 mg/kg (Cmax = 13.1 micrograms/mL) and 4.4 mg/kg (Cmax = 24.1 micrograms/mL). Ceftiofur accumulated slowly into TCF and peak concentrations were found to be approximately 14% of those observed in serum after the first dose and approximately 24% after multiple dosing. Concentrations of ceftiofur in BS were obtained rapidly with peak concentrations reaching 45% of the serum Cmax after the first dose. After multiple dosing the Cmax for BS was approximately 25% of the serum Cmax. This study found that both the 2.2 mg/kg and 4.4 mg/kg dosing regimens resulted in continuous serum, TCF and BS concentrations of ceftiofur that exceeded the minimal concentration required to inhibit the bacteria most frequently isolated from calves with acute bovine respiratory disease.     

Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.

Recombinant strains of herpesvirus of turkeys (HVT) were constructed that contain either the fusion protein gene or the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) inserted into a nonessential gene of HVT. Expression of the NDV antigens was regulated from a strong promoter element derived from the Rous sarcoma virus long terminal repeat. Recombinant HVT strains were stable and fully infectious in cell culture and in chickens. Chickens receiving a single intra-abdominal inoculation at 1 day of age with recombinant HVT expressing the NDV fusion protein had an immunological response and were protected (> 90%) against lethal intramuscular challenge at 28 days of age with the neurotropic velogenic NDV strain Texas GB. Recombinant HVT expressing the NDV hemagglutinin-neuraminidase provided partial protection (47%) against the same challenge. Chickens vaccinated with recombinant HVT vaccines had low levels of protection against NDV replication in the trachea when challenged ocularly. Recombinant HVT vaccines and the parent HVT strain provided similar levels of protection to chickens challenged with the very virulent RB1B strain of Marek's disease virus, indicating that insertion of foreign sequences into the HVT genome did not compromise the ability of HVT to protect against Marek's disease.     

Effect of porcine somatotropin on number of granulosa cell luteinizing hormone/human chorionic gonadotropin receptors, oocyte viability, and concentrations of steroids and insulin-like growth factors I and II in follicular fluid of lean and obese gilts.

Prepubertal gilts of obese (n = 24) or lean (n = 24) genetic lines were injected (s.c.) daily with 0, 2, or 4 mg of porcine somatotropin (pST) for 6 wk starting at 160 d of age to determine whether pST affects follicular function. Blood and ovaries were collected at slaughter 24 h after the last injection. Surface follicles greater than or equal to 1.0 mm in diameter were counted, and pools of follicular fluid (FFL) and granulosa cells were collected from 1.0- to 3.9-mm (small) and 4.0- to 6.9-mm (medium) follicles. Oocytes were collected from small and medium follicles and evaluated for maturational stage and viability. Porcine somatotropin increased (P less than .08) the numbers of small but not the numbers of medium follicles per gilt (P greater than .10). Oocyte maturation and viability were not affected by pST or genetic line. Porcine somatotropin increased (P less than .05) concentrations of insulin-like growth factor I (IGF-I) in serum and FFL of both obese and lean gilts; IGF-I was lower (P less than .01) in lean gilts. Treatment with pST decreased (P less than .05) IGF-II in FFL of lean but not in that of obese gilts. Dose of pST and line had no effect on concentrations of progesterone in FFL of small or medium follicles or on concentrations of estradiol in FFL of small follicles.(ABSTRACT TRUNCATED AT 250 WORDS)